Related Experiment Videos
Is dementia preventable? Focus on Alzheimer's disease
1Abarbanel Mental Health Center, Bat-Yam, 59100, Israel. mdybarak@gmail.com
Expert Review of Neurotherapeutics
|October 28, 2010
Summary
Preventing dementia, including Alzheimer's disease, involves exploring four key areas: medications, nutrition, cognitive, and physical activity. While evidence is not yet conclusive, these strategies show promise for reducing dementia risk.
Area of Science:
- Neuroscience
- Gerontology
- Public Health
Background:
- Dementia prevention, especially for Alzheimer's disease (AD), presents a significant challenge.
- Current research explores various interventions to mitigate AD risk and progression.
Purpose of the Study:
- To categorize current evidence and hypotheses on dementia prevention strategies.
- To review four primary avenues for potential preventive interventions as identified by the NIH State-of-the-Science Conference.
Main Methods:
- Literature review and synthesis of existing evidence, observations, and hypotheses.
- Categorization of interventions into antihypertensive medications, nutrition, cognitive engagement, and physical activity.
Main Results:
- Cognitive engagement and regular physical activity are associated with a reduced risk of Alzheimer's disease.
- The Mediterranean diet and omega-3 fatty acid consumption warrant further investigation for their role in prevention.
- Effective management of risk factors, particularly hypertension, forms a foundational element of Alzheimer's disease prevention.
Conclusions:
- While no single intervention is definitively proven, multiple avenues show promise for dementia prevention.
- A multi-faceted approach combining lifestyle modifications and risk factor management is crucial.
- Further research is needed to establish conclusive evidence for specific preventive strategies.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...